MPH Mittelständische Pharma Holding AG: Listing in Entry Standard

MPH Mittelständische Pharma Holding AG:
Listing in Entry Standard

The company MPH Mittelständische Pharma Holding AG today informs the shareholders that the preference share is listed in the Entry Standard (Open Market) as of today. The stock exchange trading procedure does not change.
The transparency level is higher in the Entry Standard than in the First Quotation Board (Open Market), which was used for the listing before.

About the company MPH Mittelständische Pharma Holding AG:

The Berlin based company MPH Mittelständische Pharma Holding AG has strategically concentrated its activities on growth segments in the pharmaceutical market. With pharmaceutical products based on patent-free and patent-protected active substances, which are made available through the MPH group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases, a contribution is made towards cost reduction in the healthcare sector.

MPH Mittelständische Pharma Holding AG has been listed on the stock exchange (Open Market) in Frankfurt as of September, 1, 2009. Within the Open Market a segment change - from First Quotation Board to Entry Standard - took place as of March, 16, 2012.

Key capital market data for MPH Mittelständische Pharma Holding AG:
Subscribed Capital: EUR 38.050.000
Stock exchange listed class of shares: Owner held-preferred shares
Number of circulating preference shares: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock Exchange code: 93MV

Contact:
Patricia Blechinger
MPH Mittelständische Pharma Holding AG
Hubertusallee 73
14193 Berlin
Tel. +49 (0)30 897308660  Fax. +49 (0)30 897308670
E-Mail: ir@mph-ag.de  Web. www.mph-ag.de